222 related articles for article (PubMed ID: 38615819)
1. 'Vagus Nerve Dysfunction in the Post-COVID-19 Condition' - Author's reply.
Lladós G; Massanella M; Paredes R; Mateu L
Clin Microbiol Infect; 2024 Jul; 30(7):971-972. PubMed ID: 38615819
[No Abstract] [Full Text] [Related]
2. Re: 'Vagus nerve dysfunction in the post-COVID-19 condition' by Lladós et al.
Finsterer J
Clin Microbiol Infect; 2024 Jul; 30(7):969-970. PubMed ID: 38042366
[No Abstract] [Full Text] [Related]
3. Vagus nerve dysfunction in the post-COVID-19 condition: a pilot cross-sectional study.
Lladós G; Massanella M; Coll-Fernández R; Rodríguez R; Hernández E; Lucente G; López C; Loste C; Santos JR; España-Cueto S; Nevot M; Muñoz-López F; Silva-Arrieta S; Brander C; Durà MJ; Cuadras P; Bechini J; Tenesa M; Martinez-Piñeiro A; Herrero C; Chamorro A; Garcia A; Grau E; Clotet B; Paredes R; Mateu L;
Clin Microbiol Infect; 2024 Apr; 30(4):515-521. PubMed ID: 37984511
[TBL] [Abstract][Full Text] [Related]
4. Vagus nerve inflammation contributes to dysautonomia in COVID-19.
Woo MS; Shafiq M; Fitzek A; Dottermusch M; Altmeppen H; Mohammadi B; Mayer C; Bal LC; Raich L; Matschke J; Krasemann S; Pfefferle S; Brehm TT; Lütgehetmann M; Schädler J; Addo MM; Schulze Zur Wiesch J; Ondruschka B; Friese MA; Glatzel M
Acta Neuropathol; 2023 Sep; 146(3):387-394. PubMed ID: 37452829
[TBL] [Abstract][Full Text] [Related]
5. Vagus nerve SARS-CoV-2 infection and inflammatory reflex dysfunction: Is there a causal relationship?
Andersson U; Tracey KJ
J Intern Med; 2024 Jan; 295(1):91-102. PubMed ID: 38018736
[TBL] [Abstract][Full Text] [Related]
6. Chronic cough in post-COVID syndrome: Laryngeal electromyography findings in vagus nerve neuropathy.
García-Vicente P; Rodríguez-Valiente A; Górriz Gil C; Márquez Altemir R; Martínez-Pérez F; López-Pajaro LF; García-Berrocal JR
PLoS One; 2023; 18(3):e0283758. PubMed ID: 36996121
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiome Imbalance and Neuroinflammation: Impact of COVID-19 on Parkinson's Disease.
Follmer C
Mov Disord; 2020 Sep; 35(9):1495-1496. PubMed ID: 32822087
[No Abstract] [Full Text] [Related]
8. Author's reply to the Letter to the Editor "The study of olfactory dysfunction in SARS-CoV-2 variants".
Hintschich CA; Vielsmeier V; Bohr C; Hagemann J; Klimek L
Eur Arch Otorhinolaryngol; 2022 Nov; 279(11):5471-5472. PubMed ID: 35904630
[No Abstract] [Full Text] [Related]
9. 'Post-COVID-19 chronic symptoms' - Author's reply.
Davido B; Seang S; Barizien N; Tubiana R; de Truchis P
Clin Microbiol Infect; 2021 Mar; 27(3):495-496. PubMed ID: 32898714
[No Abstract] [Full Text] [Related]
10. "Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study": Author's reply.
Klopfenstein T; Gendrin V; Zayet S
J Med Virol; 2023 Jan; 95(1):e28151. PubMed ID: 36109191
[No Abstract] [Full Text] [Related]
11. Treatment of Stage 3 COVID-19 With Transcutaneous Auricular Vagus Nerve Stimulation Drastically Reduces Interleukin-6 Blood Levels: A Report on Two Cases.
Boezaart AP; Botha DA
Neuromodulation; 2021 Jan; 24(1):166-167. PubMed ID: 33063409
[No Abstract] [Full Text] [Related]
12. Response to "The Use of Non-Invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated with COVID-19: A Theoretical Hypothesis and Early Clinical Experience".
Burger AM; D'Agostini M
Neuromodulation; 2020 Oct; 23(7):1042-1043. PubMed ID: 32762067
[No Abstract] [Full Text] [Related]
13. Response to Letter to the Editor Regarding: "The Use of Non-Invasive Vagus Nerve Stimulation to Treat Respiratory Symptoms Associated With COVID-19: A Theoretical Hypothesis and Early Clinical Experience".
Staats PS; Levy R
Neuromodulation; 2020 Oct; 23(7):1044-1045. PubMed ID: 32959499
[No Abstract] [Full Text] [Related]
14. Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research.
Kopańska M; Batoryna M; Bartman P; Szczygielski J; Banaś-Ząbczyk A
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054856
[TBL] [Abstract][Full Text] [Related]
15. Concerns regarding risk factors for SARS-CoV-2 transmission to pets: author's reply.
Alberto-Orlando S; Garcia-Bereguiain MA
Int J Infect Dis; 2023 May; 130():212-213. PubMed ID: 37030922
[No Abstract] [Full Text] [Related]
16. Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply.
Della-Torre E; Lanzillotta M; Ramirez GA; Dagna L; Tresoldi M
Eur J Intern Med; 2022 Jan; 95():98-99. PubMed ID: 34711472
[No Abstract] [Full Text] [Related]
17. Long COVID in Children up to 12 y of Age - A Retrospective Telephonic Survey: Author's Reply.
Dash N; Verma S
Indian J Pediatr; 2023 Aug; 90(8):844. PubMed ID: 37127826
[No Abstract] [Full Text] [Related]
18. Author's reply to comment on: A higher frequency of physical activity is associated with reduced rates of SARS-CoV-2 infection.
Green I; Merzon E; Vinker S; Golan-Cohen A; Israel A; Scheinowitz M; Ishai R; Magen E; Ashkenazi S
Eur J Gen Pract; 2023 Dec; 29(2):2188015. PubMed ID: 36942729
[No Abstract] [Full Text] [Related]
19. Treating COVID-19 with NRICM101 and NRICM102 - Author's reply.
Lin SJ; Lee MY; Tseng YH; Su YC
Pharmacol Res; 2022 Nov; 185():106438. PubMed ID: 36096422
[No Abstract] [Full Text] [Related]
20. Mental health during the COVID-19 pandemic and beyond: The importance of the vagus nerve for biopsychosocial resilience.
Dedoncker J; Vanderhasselt MA; Ottaviani C; Slavich GM
Neurosci Biobehav Rev; 2021 Jun; 125():1-10. PubMed ID: 33582230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
